Overview Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide). Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This study will assess the effect of concomitant antacid on the pharmacokinetics and pharmacodynamics of SMC021 Phase: Phase 2 Details Lead Sponsor: NovartisTreatments: AntacidsAnti-Ulcer AgentsCalcium CarbonateMagnesium Hydroxide